11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2014
-
Mark
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
(
- Contribution to journal › Article
- 2013
-
Mark
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
(
- Contribution to journal › Article
- 2012
-
Mark
MyelomA Genetics International Consortium
(
- Contribution to journal › Scientific review
-
Mark
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
(
- Contribution to journal › Article
- 2011
-
Mark
Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
(
- Contribution to journal › Article
- 2010
-
Mark
Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma.
(
- Contribution to journal › Article
- 2009
-
Mark
Impact of FISH and Cytogenetics On Overall and Event Free Survival in Myeloma: An IMWG Analysis of 9,897 Patients
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group
(
- Contribution to journal › Article
- 2005
-
Mark
International Staging System for Multiple Myeloma.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »